Table I.
Pathway ID | Definition | Fisher P-value | Selection counts | Size | Enrichment-score | Genes |
---|---|---|---|---|---|---|
hsa04115 | p53-signaling pathway | 0.013 | 24 | 6890 | 1.86 | APAF1//BAI1//BAX//BBC3//CASP8//CASP9//CCND3//CCNG2//CD82//CDK2//CDKN1A//CDKN2A//CHEK1//CYCS//DDB2//IGFBP3//RCHY1//RFWD2//RRM2B//SHISA5//TNFRSF10B//TP53//TSC2//ZMAT3 |
hsa04330 | Notch-signaling pathway | 0.001 | 21 | 6890 | 2.96 | APH1A//CREBBP//CTBP2//DTX1//DTX3//DVL1//DVL2//DVL3//HDAC1//HDAC2//JAG2//KAT2A//LFNG//MFNG//NCOR2//NCSTN//NOTCH1//NOTCH2//NUMB//PSENEN//RFNG |
hsa04621 | NOD-like receptor-signaling pathway | 0.005 | 22 | 6890 | 2.52 | CARD6//CARD8//CARD9//CASP5//CASP8//CHUK//CXCL1//IKBKB//MAPK13//MAPK14//MAPK3//MEFV//NFKB1//NLRP1//NLRP3//NOD1//NOD2//PSTPIP1//PYCARD//RELA//SUGT1//TNF |
hsa04668 | TNF signaling pathway | <0.001 | 41 | 6890 | 3.34 | AKT1//AKT2//BCL3//CASP10//CASP8//CEBPB//CHUK//CREB1//CREB3L2//CSF1//CXCL1//CXCL5//FADD//FOS//ICAM1//IKBKB//IL15//JUNB//MAP2K6//MAP2K7//MAP3K5//MAPK13//MAPK14// MAPK3//MMP14//MMP9//NFKB1// NOD2//PGAM5//PIK3CD//PIK3R5//PTGS2//RELA//RIPK1//RIPK3//RPS6KA5//TNF//TNFRSF1B//TRADD//TRAF1//TRAF3 |
hsa05222 | Small cell lung cancer | 0.008 | 30 | 6890 | 2.11 | AKT1//AKT2//APAF1//BCL2//CASP9//CDK2//CDKN1B//CDKN2B//CHUK//COL4A3//CYCS//E2F2//FHIT//IKBKB//ITGA3//ITGA6//ITGAV//LAMA5//LAMB2//LAMC3//MYC//NFKB1//PIK3CD//PIK3R5//PTGS2//RELA//TP53//TRAF1//TRAF3//TRAF4 |
hsa05223 | Non-small cell lung cancer | 0.004 | 19 | 6890 | 1.399 | AKT1//AKT2//ARAF//CASP9//CDKN2A//E2F2//FHIT//GRB2//HRAS//MAPK3//PDPK1//PIK3CD//PIK3R5//PLCG1//PRKCA//PRKCB//RASSF1//TGFA//TP53 |
CDKN2A is in the p53-signaling pathway. The Fisher P-values were 0.013 and 0.0039. CDKN2A was identified to be concentrated on the p53-signaling pathway according to the high-throughput sequencing results. TNF, tumor necrosis factor; CDKN2A, cyclin dependent kinase inhibitor 2A; NOD, nucleotide-binding oligomerization domain.